Connect with us

Hi, what are you looking for?

Investing

Injective Revenue to FDV Ratio Tops Major Blockchains: Can INJ Benefit?

The post Injective Revenue to FDV Ratio Tops Major Blockchains: Can INJ Benefit? appeared first on Coinpedia Fintech News

Injective is making a numbers driven pitch to crypto investors. Its revenue to fully dilution valuation (FDV) ratio now leads the major blockchain platforms shown in the year 2026 year to date comparison, putting INJ ahead of better known rivals on this particular metric. The catch? A strong ratio can support a valuation argument, but …

    You May Also Like

    Stock

    A company that just posted the largest quarterly operating profit in the history of the technology industry should not see its stock fall 7%...

    Stock

    The consensus story about Samsung Electronics is that you buy it for the memory supercycle. That story is incomplete, and the part everyone is...

    Stock

    SK Hynix is not trading at seven times earnings, whatever the screen says. The Korean memory maker closed at ₩1,678,000 on 25 August 2026,...

    Stock

    Index inclusion is not a re-rating. Reddit (RDDT) closed at $178.09 on August 14, 2026, up 12.63% on the session that confirmed its entry...